These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34234695)

  • 1. Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.
    Kaur N; Guan Y; Raja R; Ruiz-Velasco A; Liu W
    Front Physiol; 2021; 12():694864. PubMed ID: 34234695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
    Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
    Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.
    Salvatore T; Pafundi PC; Galiero R; Albanese G; Di Martino A; Caturano A; Vetrano E; Rinaldi L; Sasso FC
    Front Med (Lausanne); 2021; 8():695792. PubMed ID: 34277669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
    Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage.
    Elia E; Ministrini S; Carbone F; Montecucco F
    Minerva Cardiol Angiol; 2022 Jun; 70(3):357-369. PubMed ID: 33427423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids.
    Jubaidi FF; Zainalabidin S; Mariappan V; Budin SB
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies.
    Ghosh N; Chacko L; Bhattacharya H; Vallamkondu J; Nag S; Dey A; Karmakar T; Reddy PH; Kandimalla R; Dewanjee S
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
    Parim B; Sathibabu Uddandrao VV; Saravanan G
    Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF-β signaling pathway.
    Seksaria S; Mehan S; Dutta BJ; Gupta GD; Ganti SS; Singh A
    J Biochem Mol Toxicol; 2023 May; 37(5):e23330. PubMed ID: 36890713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy.
    Mathur P; Rani V
    Curr Gene Ther; 2021; 21(4):313-326. PubMed ID: 33719971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y; Sharma SS
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
    Borghetti G; von Lewinski D; Eaton DM; Sourij H; Houser SR; Wallner M
    Front Physiol; 2018; 9():1514. PubMed ID: 30425649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay of inflammation, exosomes and Ca
    Sanganalmath SK; Dubey S; Veeranki S; Narisetty K; Krishnamurthy P
    Cardiovasc Diabetol; 2023 Feb; 22(1):37. PubMed ID: 36804872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients.
    Nikolajević Starčević J; Janić M; Šabovič M
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
    Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
    Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
    Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.